Autonomix
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Waterway Ave Ste 300, The Woodlands, ...Phone Number
(713) 588-6150Website
www.autonomix.comRevenue
-Stock Symbol
AMIXIndustry
About Autonomix
Autonomix Org Chart
Is Autonomix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Autonomix is spiking on competitors!
Earning: See what the market has to say on Autonomix recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Autonomix
Autonomix, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Autonomix has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Autonomix launches new products
Funding: Get notified immidiatlly once Autonomix has new funding data
Click to see if Autonomix had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Autonomix
Compare insights from companies similar to Autonomix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Autonomix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Autonomix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Autonomix.
Autonomix financials insights
Gather financial insights about Autonomix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Stock Offering
$11.1M
Autonomix Tech Stack
A closer look at the technologies used by Autonomix
Most Recent Scoops
Autonomix News & Media
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wallAutonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
THE WOODLANDS, TX, May 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that two abstracts highlighting the Company’s innovative transvascular nerve-targeting platform technology have been accepted for presentation at EuroPCR 2026, the world-leading course in interventional cardiovascular medicine, taking place May 19–22, 2026 in Paris, France.Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
THE WOODLANDS, TX, April 29, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced its long-term data titled “Pain Mitigation in Pancreatic Adenocarcinoma: A Long-Term Analysis of Denervation via Transvascular RF Energy-Based Ablation” has been accepted for presentation at Digestive Disease Week 2026 (DDW 2026), being held May 2–5, 2026, in Chicago, IL anAutonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026
THE WOODLANDS, TX, April 22, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that new long-term clinical data evaluating its transvascular radiofrequency (RF) ablation approach for pain mitigation in pancreatic adenocarcinoma will be presented at the European Conference on Interventional Oncology (ECIO) 2026 being held April 26 – 30, 2026 in Basel C
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Autonomix
Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural si... Read More